These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Clinical experience with sternotomy versus subcostal approach for exchange of the HeartMate XVE to the HeartMate II ventricular assist device. Gregoric ID, Bruckner BA, Jacob L, Kar B, Cohn WE, La Francesca S, Frazier OH. Ann Thorac Surg; 2008 May; 85(5):1646-9. PubMed ID: 18442556 [Abstract] [Full Text] [Related]
9. The impact of bridge-to-transplant ventricular assist device support on survival after cardiac transplantation. Bull DA, Reid BB, Selzman CH, Mesley R, Drakos S, Clayson S, Stoddard G, Gilbert E, Stehlik J, Bader F, Kfoury A, Budge D, Eckels DD, Fuller A, Renlund D, Patel AN. J Thorac Cardiovasc Surg; 2010 Jul; 140(1):169-73. PubMed ID: 20451930 [Abstract] [Full Text] [Related]
11. Histopathologic correlates of myocardial improvement in patients supported by a left ventricular assist device. Segura AM, Frazier OH, Demirozu Z, Buja LM. Cardiovasc Pathol; 2011 Jul; 20(3):139-45. PubMed ID: 20185339 [Abstract] [Full Text] [Related]
12. Longitudinal change in quality of life and impact on survival after left ventricular assist device implantation. Grady KL, Meyer PM, Dressler D, Mattea A, Chillcott S, Loo A, White-Williams C, Todd B, Ormaza S, Kaan A, Costanzo MR, Piccione W. Ann Thorac Surg; 2004 Apr; 77(4):1321-7. PubMed ID: 15063260 [Abstract] [Full Text] [Related]
14. Low thromboembolic risk for patients with the Heartmate II left ventricular assist device. John R, Kamdar F, Liao K, Colvin-Adams M, Miller L, Joyce L, Boyle A. J Thorac Cardiovasc Surg; 2008 Nov; 136(5):1318-23. PubMed ID: 19026822 [Abstract] [Full Text] [Related]
15. Left ventricular assist devices as destination therapy: a new look at survival. Park SJ, Tector A, Piccioni W, Raines E, Gelijns A, Moskowitz A, Rose E, Holman W, Furukawa S, Frazier OH, Dembitsky W. J Thorac Cardiovasc Surg; 2005 Jan; 129(1):9-17. PubMed ID: 15632819 [Abstract] [Full Text] [Related]
17. Cardiac transplantation for cardiac sarcoidosis with initial diagnosis by examination of the left ventricular apical "core" excised for insertion of a left ventricular assist device for severe chronic heart failure. Roberts WC, Vowels TJ, Ko JM, Capehart JE, Hall SA. Am J Cardiol; 2009 Jan 01; 103(1):110-4. PubMed ID: 19101239 [Abstract] [Full Text] [Related]
18. Time course of reverse remodeling of the left ventricle during support with a left ventricular assist device. Madigan JD, Barbone A, Choudhri AF, Morales DL, Cai B, Oz MC, Burkhoff D. J Thorac Cardiovasc Surg; 2001 May 01; 121(5):902-8. PubMed ID: 11326233 [Abstract] [Full Text] [Related]
19. Renal and hepatic function improve in advanced heart failure patients during continuous-flow support with the HeartMate II left ventricular assist device. Russell SD, Rogers JG, Milano CA, Dyke DB, Pagani FD, Aranda JM, Klodell CT, Boyle AJ, John R, Chen L, Massey HT, Farrar DJ, Conte JV, HeartMate II Clinical Investigators. Circulation; 2009 Dec 08; 120(23):2352-7. PubMed ID: 19933938 [Abstract] [Full Text] [Related]